drug
-
Syngene to acquire multi-modal facility from Stelis Biopharma
To add 20,000 litres of installed biologics drug substance manufacturing capacity Syngene announced the acquisition of Unit 3 biologics manufacturing…
Read More » -
IIT Kanpur researchers paves way for new drug discovery
The discovery has led to the identification of a novel mechanism responsib e for regulating the function of GPCRs in…
Read More » -
GeneQuantum, WuXi XDC in partnership to empower innovative bioconjugates development
GeneQuantum will develop multiple ADC drugs through collaboration with Wuxi XDC GeneQuantum Healthcare (GQ), a global innovative biotechnology company dedicated…
Read More » -
Piramal Pharma Solutions launches ADCelerate
ADCelerate is a new, branded solution for antibody-drug conjugate drug development Piramal Pharma Solutions announced the launch of ADCelerate, a new, branded…
Read More »